A comparative study of efficiency of different ivermectin medicinal forms for treating helmintosis in live-stock animals
Keywords:helmintosis, ivermectin, parasites
AbstractA comparative study of efficiency of injection and oral forms of ivermectin has been conducted. The research results indicate that efficiency of drugs with ivermectin against endoparasites is very high and reaches 100%. The exception is Oesophagostomum dentatum, the therapeutic effectiveness against it in some cases was less – from 85% to 95%. The therapeutic effectiveness in experimental groups is 100%; it confirms the complete parasites elimination by “Neoverm” in the doses from 0.2 to 0.3 mg/kg when using it twice and in the dose of 0.3 mg/kg with a single use. The single use of “Neoverm” in the doses lower than 0.3 mg/kg does not provide the complete elimination of parasites. The use of drugs with ivermectin – “Neoverm” and “Intramek” based on a nanoemulsion provides the therapeutic effect even after single administration. In spite of the fact that a single administration of injection drug ”Intramek” in the recommended dose of 0.3 мg/kg did not result in the complete elimination of O. dentatum, its efficiency can be considered as rather sufficient compared to the oral drug “Neoverm”. The oral 0.6% ivermectin premix also showed high efficiency against endoparasites, except for O. dentatum. The use of injection and oral drugs with ivermectin– “Neoverm” and “Intramek” based on nanoemulsions is technologically more advantageous for farms than application of the oral premix since these drugs provide a therapeutic effect even after a single administration, while the premix must be given during a week. The therapeutic effectiveness of “Neoverm” and “Intramek” can be considered as equivalent. It is obvious that oral drug “Neoverm” will be beneficial for large livestock and injection “Intramek” – for small farms.
Галат В.Ф., Березовський А.В., Прус М.П., Сорока Н.М. Паразитологія та інвазійні хвороби тварин – К.: Урожай, 2009. - 363с.
Кузьмин А.А. Антгельминтики в ветеринарной медицине – К.: Аквариум Лтд, 2004. - 144с.
Соколов Ю.В., Хасбауи Х.А. // Сучасне птахівництво. - 2014. - №3(136). - с.18-20.
Campbell W.C. // Parasitol. Today. 1990. - V.6. - P.130-133.
Campbell W.C. // New York, Berlin, Heidelberg, London, Paris, Tokyo.- 1989.- P. 1-25,244-259.
Fryd M.M., Mason T.G. // Annu. Rev. Phys. Chem. - 2012. - Vol.63. - P.493–518.
IVOMEC PREMIX FOR SWINE 0.6% // Compendium of Veterinary Products. - [Електрон. ресурс].– Спосіб доступу: http://merialce.naccvp.com/product/view/1182040 – Заголовок з екрана.
Lovelyn C., Attama A.A. // Journal of Biomaterials and Nanobiotechnology. - 2011. - Vol.2. - P.626-639.
Salata O. // J. Nanobiotechnology. – 2004. - Vol.2.- P.3.
Shah P., Bhalodia D., Shelat P. // Systematic Reviews in Pharmacy. - 2010. - Vol. 1, № 1. - P. 24-32.
Speiser P.P. // Methods Find. Exp. Clin. Pharmacol.-1991.- №13.- P.337-342.
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).